金迪克: 江苏金迪克生物技术股份有限公司第二届监事会第十一次会议决议公告

Meeting Overview - The second meeting of the Supervisory Board of Jiangsu Jindike Biotechnology Co., Ltd. was held on August 21, 2025, combining in-person and remote participation, with all three supervisors present for voting [1]. Resolutions Passed - The Supervisory Board unanimously approved the 2025 Half-Year Report and its summary, confirming that the report's preparation and review complied with relevant laws and internal regulations, and accurately reflected the company's operational and financial status for the first half of 2025 [1][2]. - The Supervisory Board also approved the Special Report on the Storage and Actual Use of Raised Funds for the first half of 2025, affirming that the use of raised funds adhered to regulatory requirements and did not harm the interests of the company or its shareholders [2][3].